Ofev®
nintedanib esylate
Treatment of patients with idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and, in some countries, other chronic fibrosing interstitial lung diseases with a progressive phenotype.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD) and, in some countries, other chronic fibrosing interstitial lung diseases with a progressive phenotype
Brand Names
Ofev®
Active ingredients
nintedanib esylate